Antibacterial activities against <i>Ralstonia solanacearum</i> and <i>Xanthomonas oryzae pv</i>. <i>oryzae</i> of 6-chloro-4-(4-substituted piperazinyl)quinazoline derivatives

Wu-Bin Shao,Yu-Tao Zheng,Jia-Min Liu,Yi-Hong Fu,Pu-Ying Qi,Xiang Zhou,Zhi-Bing Wu,Pei-Yi Wang,Song Yang
DOI: https://doi.org/10.1016/j.bmcl.2019.126912
IF: 2.94
2020-01-01
Bioorganic & Medicinal Chemistry Letters
Abstract:In this letter, a variety of simple 6-chloro-4-(4-substituted piperazinyl)quinazoline derivatives was prepared. Preliminary bioassays revealed that these compounds showed good antibacterial activities toward phytopathogens Ralstonia solanacearum and Xanthomonas oryzae pv. oryzae (Xoo). Among these derivatives, compounds 5a, 5d, 5e, 5f, 5p, 5q, 6b, and 6d exhibited potent inhibition effects against R. solanacearum with EC50 within 4.60-9.94 mu g/mL, especially, compound 5g exerted the strongest activity with EC50 of 2.72 mu g/mL; compound 6b possessed the best inhibitory activity toward Xoo with EC50 of 8.46 mu g/mL. Subsequently, a good predictive three-dimensional quantitative structure-activity relationship (3D-QSAR) model was constructed via CoMFA to direct the future structural modification and optimization. Furthermore, the pathogens' topological studies were performed to explore the possible antibacterial mechanism. Given their simple frameworks and facile synthesis, title compounds can serve as the potential antibacterial leads.
What problem does this paper attempt to address?